KALARIS THERAPEUTICS, INC.
Last · NASDAQ$2.13-0.10 (-4.48%)close · yahoo · 18h ago
Market cap$50.70M23.8M sh
P/E · TTM-1.1fwd -1.3 · eps -2.02 · loss
Beta—vs S&P 500
Div yield0.00%annual · TTM
52w range
$2.11$11.88
Volume21.0Ksession
Loading chart…
Press & signals
- GlobeNewswire
Kalaris Reports Second Quarter 2026 Financial Results and Provides Business Updates
- GlobeNewswire
Kalaris Expands Leadership Team Appointing Liisa Bayko as Chief Financial Officer
Documents
FormReporting forFiledFlags